Serve as SDTL Responsible for planning and leading the delivery of all components of a clinical study to time, cost, and quality from Study Specifications (SS) through study closeout activities and Clinical Study Report (CSR). Form a motivated and aligned
Serve as SDTL Responsible for planning and leading the delivery of all components of a clinical study to time, cost, and quality from Study Specifications (SS) through study closeout activities and Clinical Study Report (CSR). Form a motivated and aligned
Essential Functions QC of project database(s) and requisition forms versus the sponsor protocol and sponsor specific requirements. Cross functional collaboration to ensure QC reviews reflect current process and quality standards. . Work with Set-up Managers and/or
Job Overview: Site monitoring and site management responsibility for clinical studies according to Company, and/or Sponsor, Standard Operating Procedures, and Regulatory Guidelines. Assures the implementation of project plans, as assigned. Summary of Responsibilities: Responsible for all aspects
Job Overview: The Senior Clinical Research Associate II (Sr CRA II) is responsible and accountable for site monitoring and site management for clinical studies according to Fortrea, and/or Sponsor, Standard Operating Procedures, and Regulatory Guidelines. The Sr
Job Overview: Site monitoring and site management responsibility for clinical studies according to Company, and/or Sponsor, Standard Operating Procedures, and Regulatory Guidelines. Assures the implementation of project plans, as assigned. Summary of Responsibilities: Responsible for all aspects
Job Overview Work performed is in accordance with ICH E6 Guideline for Good Clinical Practice. Essential Functions • Collect all deliveries from loading bay, log, QC, receipt in, store and distribute as required • Maintain stock
Work ScheduleStandard (Mon-Fri) Environmental ConditionsOffice Job DescriptionJoin Us as a Clinical Trial Coordinator – Make an Impact at the Forefront of Innovation We have successfully supported the top 50 pharmaceutical companies and more than 750 biotechs, spanning